London – 24 October 2016 – inVentiv Health, a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market, today announced the appointment of Julie Adrian as Managing Director for Communications in Europe. Adrian will now lead more than 300 European advertising, digital, public relations, medical communications, research, market access and clinical trial recruitment professionals. Adrian was previously U.S. Managing Director at Chandler Chicco Agency, where she grew both public relations and integrated communications offerings.
inVentiv Health Communications brings together best-in-class agencies to think and deliver as one integrated team. Adrian’s appointment as EU Managing Director unites the inVentiv Health Communications agencies, which include PR, advertising and medical communications, under a singular leader who will work across disciplines and offices to support inVentiv Health’s top talent while continuing to fuel EU growth. Adrian will oversee operations in London, Munich, Frankfurt and Paris and will report to Lisa Stockman, President of inVentiv Health Communications.
“Julie has the industry knowledge and internal connections to accelerate our growth strategy in Europe. She is a seasoned leader and team builder who has successfully grown our West Coast and U.S. presence for the past 13 years, often expanding U.S. business into global markets,” said Stockman. “We’re excited about our future in the EU given client demands for more integrated solutions designed to solve complex health challenges.”
Further bolstering EU leadership is the promotion of Joanne Wunder to European Managing Director of inVentiv Health Public Relations Group, which includes Biosector 2, Chamberlain Healthcare PR, Chandler Chicco Agency and Frankfurt-based Haas & Health. The EU PR group has nearly 80 employees offering best-in-class capabilities spanning public relations, digital and social media, disease awareness, advocacy, clinical trial recruitment and analytics and measurement. Their collective expertise creates communications that drive corporate value, enhance brand perception and deliver on the bottom line.
“Jo has the expertise and passion to continue to strengthen our public relations offering through the delivery of multichannel communications solutions,” said Adrian, to whom Wunder will report. “The team is stacked with best-in-class talent who create exceptional programs for clients and work to live up to our industry awards and recognition every day.”
Adrian brings more than 25 years of experience to the development and execution of healthcare communications programs in her new role. Prior to leading the agency’s U.S. and West coast operations where she delivered strong year-on-year growth, Adrian provided strategic marketing and corporate communications counsel for pharmaceutical, biotech and device clients while at Cohn & Wolfe, Fleishman-Hillard and Hoechst Marion Roussel (now Sanofi). Just this year, Adrian was named to the PharmaVOICE 100 list honoring the 100 most inspiring leaders in the life sciences industry.
Wunder has more than 20 years of experience providing senior strategic counsel to global pharmaceutical clients, including planning and implementing pre-launch and launch public relations campaigns for a variety of brands ranging from blockbusters to orphan drugs. She has extensive experience in stakeholder engagement and scientific data communications. Prior to joining inVentiv, Wunder held a senior role at Ogilvy Health PR, London, where she was responsible for leading multichannel disease awareness campaigns and the healthcare social media practice.
Beyond the communications disciplines, inVentiv Health Communications professionals have the ability to tap the expertise of 15,000 clinical and commercial colleagues worldwide to infuse programs with deep therapeutic and analytic insights.
About inVentiv Health Communications
inVentiv Health Communications brings together best-in-class agencies across advertising, digital, public relations, medical communications, research, market access and clinical trial recruitment. With a unique lens from clinical development through commercialization, our specialists understand the human side of healthcare and think and deliver as one integrated team. We have the data, insights, creativity and knowledge to create exceptional global, multichannel communications for organizations focused on health and wellness. Together, we are driving a new era of more measureable and innovative marketing.
About inVentiv Health
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Our combined Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services, processes and integrated solutions that improve client performance. With more than 15,000 employees and the ability to support clients in 90 countries, our global scale and deep therapeutic expertise enable inVentiv to help clients successfully navigate an increasingly complex environment. For more information, visit inVentivHealth.com.